{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:07:15Z","timestamp":1791824835575,"version":"4.3.4"},"reference-count":22,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Early and accurate diagnosis of HIV remains a cornerstone of public health strategies. This study aimed to evaluate the predictive value of signal-to-cutoff (S\/CO) ratios from two fourth-generation HIV screening assays (Abbott Architect and Alinity) and to analyze diagnostic trends across pre-pandemic, pandemic, and post-pandemic periods in a low-prevalence setting. We retrospectively analyzed 197,642 unique HIV screening tests conducted at Bursa Uluda\u011f University Hospital from 2015 to 2024. Receiver operating characteristic (ROC) analysis was used to determine optimal S\/CO thresholds for distinguishing true-positive results. Of the 197,642 samples screened, the overall HIV prevalence was 0.5%, with 196 cases (0.1%) confirmed as new diagnoses. The Architect assay showed an optimal S\/CO threshold of \u226511.8 (sensitivity 98.3%, specificity 97.3%). The Alinity assay demonstrated 100% sensitivity and specificity at an S\/CO threshold of \u226519.1. Although a temporary decline in test volume occurred in 2020, there was no statistically significant difference in confirmation rates across years. During the pandemic, newly diagnosed individuals were significantly older and had lower CD4 counts, indicating delayed diagnosis (p = 0.026 and 0.008, respectively). Men who have sex with men (MSM)-related transmission significantly increased post-pandemic (p = 0.032). S\/CO ratio\u2013guided interpretation enhances diagnostic accuracy and may reduce unnecessary confirmatory testing, especially in low-prevalence and resource-limited regions. Selecting the optimal threshold can help to ensure a timely diagnosis and optimize HIV screening algorithms.<\/jats:p>","DOI":"10.3390\/v17091179","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T08:01:01Z","timestamp":1756454461000},"page":"1179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Diagnostic Value of Signal-to-Cutoff Ratios in Architect and Alinity HIV Screening Assays: A 10-Year Experience in a Pandemic-Affected, Low-Prevalence Setting"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-4989","authenticated-orcid":false,"given":"\u0130mran","family":"Sa\u011fl\u0131k","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Bursa Uludag University, Bursa 16120, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1725-0644","authenticated-orcid":false,"given":"Melda","family":"Payasl\u0131o\u011flu","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Bursa Uludag University, Bursa 16120, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-1706","authenticated-orcid":false,"given":"Hatice","family":"Orta\u00e7","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Institute of Health Sciences, Bursa Uludag University, Bursa 16120, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fclya","family":"Ayma R\u00fczgar","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Bursa Uludag University, Bursa 16120, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2025, July 01). The Global Health Observatory: Data on the Size of the HIV Epidemic. Available online: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/indicator-groups\/indicator-group-details\/GHO\/number-of-people-(all-ages)-living-with-hiv."},{"key":"ref_2","unstructured":"The Global Fund (2025, July 01). UNAIDS and Global Fund Sign a New Strategic Framework for Their Collaboration to End AIDS. Available online: https:\/\/www.theglobalfund.org\/en\/news\/2024\/2024-06-24-unaids-global-fund-new-strategic-framework-collaboration-end-aids\/."},{"key":"ref_3","unstructured":"Ministry of Health of T\u00fcrkiye (2025, July 01). HIV\/AIDS \u0130statistikleri, (In Turkish)."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/S2352-3018(20)30211-3","article-title":"Potential Effects of Disruption to HIV Programmes in sub-Saharan Africa Caused by COVID-19: Results from Multiple Mathematical Models","volume":"7","author":"Jewell","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_5","unstructured":"UNAIDS (2025, July 05). Global HIV & AIDS Statistics\u2014Fact Sheet. Available online: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Timofeeva, A., Sedykh, S., and Nevinsky, G. (2022). Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities. Vaccines, 10.","DOI":"10.3390\/vaccines10030384"},{"key":"ref_7","unstructured":"World Health Organization (WHO) (2025, July 01). Updated 2024 Consolidated Guidelines on HIV Testing Services, Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-hiv-hepatitis-and-stis-library\/updated-2024-consolidated-hts-guidelines---slides.pdf."},{"key":"ref_8","unstructured":"Abbott Laboratories (2025, August 18). Alinity s HIV Ag\/Ab Combo Assay\u2014Package Insert, Available online: https:\/\/www.fda.gov\/media\/129279\/download."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Augusto, \u00c2.D.R., Iriemenam, N.C., Kohatsu, L., de Sousa, L., Maueia, C., Hara, C., Mula, F., Cuamba, G., Chelene, I., and Langa, Z. (2020). High Level of HIV False Positives Using EIA-Based Algorithm in Survey: Importance of Confirmatory Testing. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239782"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Demir, T., Yalcin, S., and Kilic, S. (2020). Evaluation of the Diagnostic Performance and Optimal Cutoff Value of a Fourth-Generation ELISA, VIDAS HIV-1\/2 Duo Ultra Assay, in a Low-Prevalence Country. Diagn. Microbiol. Infect. Dis., 97.","DOI":"10.1016\/j.diagmicrobio.2020.115011"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e23671","DOI":"10.1002\/jcla.23671","article-title":"Performance Evaluation of Immunoassay for Infectious Diseases on the Alinity i System","volume":"35","author":"Nam","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Guo, Y.F., Yan, S.D., Xie, J.W., Wang, M., Lin, Y.Q., and Lin, L.R. (2023). Using signal-to-cutoff ratios of HIV screening assay to predict HIV infection. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08891-9"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105707","DOI":"10.1016\/j.dib.2020.105707","article-title":"Data on the Relationship of Signal-to-Cutoff Ratio of Two HIV Antigen\/Antibody Combination Assays to Subsequent Confirmation of HIV-1 Infection in a Low-Prevalence Population","volume":"31","author":"Hodgson","year":"2020","journal-title":"Data Brief"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/JCM.03583-14","article-title":"A Signal-to-Cutoff Ratio in the Abbott Architect HIV Ag\/Ab Combo Assay That Predicts Subsequent Confirmation of HIV-1 Infection in a Low-Prevalence Setting","volume":"53","author":"Jensen","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcv.2018.04.002","article-title":"Evaluation of the Architect HIV Ag\/Ab Combo Assay in a Low-Prevalence Setting: The Role of Samples with a Low S\/CO Ratio","volume":"103","author":"Alonso","year":"2018","journal-title":"J. Clin. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Whitney, E., Pitrak, D., Beavis, K.G., Moore, N.M., Shankaran, S., Abeleda, A.P., Schmitt, J., and Sha, B.E. (2022). Utility of the Signal-to-Cutoff Ratio and Antigen Index from Fourth- and Fifth-Generation HIV-1\/HIV-2 Antigen\/Antibody Assays for the Diagnosis of Acute HIV Infection: Applicability for Real-Time Use for Immediate Initiation of Antiretroviral Therapy. J. Clin. Microbiol., 60.","DOI":"10.1128\/jcm.01204-22"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1097\/QAD.0000000000002677","article-title":"Viral Suppression Rates in a Safety-Net HIV Clinic in San Francisco Destabilized during COVID-19","volume":"34","author":"Spinelli","year":"2020","journal-title":"AIDS"},{"key":"ref_18","unstructured":"UNAIDS (2025, July 01). 2021 Global AIDS Update\u2014Confronting Inequalities: Lessons for Pandemic Responses from 40 Years of AIDS. Available online: https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021-global-aids-update."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.15585\/mmwr.mm7125a2","article-title":"HIV Testing before and during the COVID-19 Pandemic\u2014United States, 2019\u20132020","volume":"71","author":"DiNenno","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/QAI.0000000000002620","article-title":"Perceived Interruptions to HIV Prevention and Treatment Services Associated with COVID-19 for Gay, Bisexual, and Other Men Who Have Sex with Men in 20 Countries","volume":"87","author":"Rao","year":"2021","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/1570162X18666200427223823","article-title":"Temporal Trends in the Epidemiology of HIV in Turkey","volume":"18","author":"Erdinc","year":"2020","journal-title":"Curr. HIV Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","article-title":"HIV Infection","volume":"9","author":"Bekker","year":"2023","journal-title":"Nat. Rev. Dis. Primers"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:34:56Z","timestamp":1760034896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["v17091179"],"URL":"https:\/\/doi.org\/10.3390\/v17091179","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}